Premium
Surveillance after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal squamous cell carcinoma
Author(s) -
Katada Chikatoshi,
Muto Manabu,
Tanabe Satoshi,
Higuchi Katsuhiko,
Sasaki Tohru,
Azuma Mizutomo,
Ishido Kenji,
Masaki Takashi,
Nakayama Meijin,
Okamoto Makito,
Koizumi Wasaburo
Publication year - 2013
Publication title -
digestive endoscopy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.5
H-Index - 56
eISSN - 1443-1661
pISSN - 0915-5635
DOI - 10.1111/j.1443-1661.2012.01407.x
Subject(s) - medicine , endoscopic mucosal resection , esophageal cancer , endoscopic submucosal dissection , esophageal squamous cell carcinoma , esophageal neoplasm , metastasis , carcinoma , cancer , lymph node metastasis , radiology , oncology , gastroenterology , endoscopy
The objectives of surveillance after endoscopic mucosal resection ( EMR ) or endoscopic submucosal dissection ( ESD ) for esophageal squamous cell carcinoma are: (i) early detection and treatment of recurrence; and (ii) early detection and treatment of metachronous esophageal squamous cell carcinoma and second primary cancers. Protocols for follow up after EMR or ESD for esophageal squamous cell carcinoma should be based on the risks of lymph node metastasis and distant metastasis as assessed on the basis of tumor staging at initial treatment. Early detection of recurrence or metachronous carcinomas often allows curative or less invasive treatment. Particular attention should be paid to the development of metachronous esophageal squamous cell carcinomas and second primary cancers (in particular, head and neck cancer and gastric cancer because of their high incidence).